Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4240/wjgs.v8.i3.212 http://scihub22266oqcxt.onion/10.4240/wjgs.v8.i3.212 C4807322!4807322!27022448     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       World+J+Gastrointest+Surg 2016 ; 8 (3): 212-21 Nephropedia Template TP {{tp|p=27022448|t=2016. Duodenal adenocarcinoma: Advances in diagnosis and surgical management |pdf=|usr=}}{{27022448}} gab.com Text Duodenal adenocarcinoma: Advances in diagnosis and surgical management JO: World J Gastrointest Surg http://www.kidney.de/pget.php?&tw=1&pmid=27022448 #FOAvip Duodenal adenocarcinoma is a rare but aggressive malignancy. Given its rarity, previous studies have traditionally combined duodenal adenocarcinoma (DA) with either other periampullary cancers or small bowel adenocarcinomas, limiting the available data to guide treatment decisions. Nevertheless, management primarily involves complete surgical resection when technically feasible. Surgery may require pancreaticoduodenectomy or segmental duodenal resection; either are acceptable options as long as negative margins are achievable and an adequate lymphadenectomy can be performed. Adjuvant chemotherapy and radiation are important components of multi-modality treatment for patients at high risk of recurrence. Further research would benefit from multi-institutional trials that do not combine DA with other periampullary or small bowel malignancies. The purpose of this article is to perform a comprehensive review of DA with special focus on the surgical management and principles. Twit Text FOAVip Duodenal adenocarcinoma: Advances in diagnosis and surgical management ????World J Gastrointest Surg http://www.kidney.de/pget.php?&tw=1&pmid=27022448 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27022448 #FOAvip English Wikipedia <ref>{{Cite pmid|27022448}}</ref> Duodenal adenocarcinoma: Advances in diagnosis and surgical management #MMPMID27022448 Cloyd JM; George E; Visser BC World J Gastrointest Surg 2016[Mar]; 8 (3): 212-21 PMID27022448show ga Duodenal adenocarcinoma is a rare but aggressive malignancy. Given its rarity, previous studies have traditionally combined duodenal adenocarcinoma (DA) with either other periampullary cancers or small bowel adenocarcinomas, limiting the available data to guide treatment decisions. Nevertheless, management primarily involves complete surgical resection when technically feasible. Surgery may require pancreaticoduodenectomy or segmental duodenal resection; either are acceptable options as long as negative margins are achievable and an adequate lymphadenectomy can be performed. Adjuvant chemotherapy and radiation are important components of multi-modality treatment for patients at high risk of recurrence. Further research would benefit from multi-institutional trials that do not combine DA with other periampullary or small bowel malignancies. The purpose of this article is to perform a comprehensive review of DA with special focus on the surgical management and principles. äDuodenal adenocarcinoma: Advances in diagnosis and surgical management(epmc).pdf DeepDyve Pubget Overpricing